Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00874627Not ApplicableCompleted

Sublingual Milk Immunotherapy in Children

Role: collaborator

NCT06493786Not ApplicableNot Yet Recruiting

Identification of Olfactory Biomarkers of Skin Cancer From Skin Odor Samples: a Pilot Study

Role: collaborator

NCT04189029Active Not Recruiting

PACIFIC-PRESERVED : PhenomApping, ClassIFication, and Innovation for Cardiac Dysfunction - HF With PRESERVED LVEF Study

Role: collaborator

NCT05113602Not ApplicableCompleted

Validation of the EEG Signal Quality Measured by the URGOnight Device and Comparison With a Clinical Device

Role: collaborator

All 4 trials loaded